Allergen immunotherapy is the only curative treatment of IgE-mediated type I respiratory allergies. Subcutaneous immunotherapy (SCIT) is used as a reference therapy and has transformed allergic treatments; it improves symptoms (asthma and rhinitis) as well as the quality of life of patients. SCIT requires repetitive administration and carries the risk of severe systemic adverse effects, including anaphylaxis. Sublingual immunotherapy (SLIT) is now a valid noninvasive alternative to SCIT, as a safe and efficacious treatment for respiratory allergies. In this article, we compare various routes of allergen immunotherapy, including SCIT and SLIT, as well as more exploratory routes currently under investigation (i.e., intralymphatic, epicutaneous, intranasal and oral). We discuss their respective advantages, as well as their foreseen modes of action.
Posted: 04/10/2012; Immunotherapy. 2012;4(2):201-212.
http://www.medscape.com/viewarticle/761450
Subscribe to:
Post Comments (Atom)
Mother and daughter getting allergy skin tests. Click on the photo to see a You Tube interview with another parent and child.
No comments:
Post a Comment